anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Paragraph

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 118,471
Current window 81,691-81,720
Pages 3,950
Rows per page 30
Component: Paragraphclear collectionreset all
18 30 60

Component

81,691-81,720 of 118,471

filter-aware
236
The slide uses a pie chart to visualize the geographic concentration of trial participants, specifically pointing out the high percentage in Russia to support a claim of data manipulation.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
238
The slide highlights a discrepancy between the trial paper's log-scale chart and the actual linear-scale data, suggesting data manipulation or misleading presentation.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
247
The slide serves as a qualitative research summary based on 16 expert interviews.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
253
The slide presents a qualitative anecdote from a physician interview regarding drug safety.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
255
The slide uses a Q&A format to present qualitative feedback from a medical expert.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
258
The slide uses a Q&A format to highlight negative sentiment from a key opinion leader (KOL).Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
259
The slide highlights a negative expert opinion on drug efficacy, contrasting it with the prescriber's own behavior.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
260
The slide uses a Q&A format to validate the negative sentiment expressed in the summary header.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
263
The slide uses a Q&A format to highlight the tightening reimbursement environment for a specific drug.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
264
Includes direct quotes from the physician regarding his clinical experience and frustrations with insurance paperwork.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
268
The slide uses highlighted text to emphasize the doctor's skepticism regarding the drug's 'game-changer' status and the saturation of his patient base.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
274
The slide presents qualitative expert testimony regarding drug discontinuation rates.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
277
The slide uses a Q&A format to validate the prescriber's credentials and patient volume.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
279
The slide highlights key negative sentiment regarding market saturation and physician adoption hurdles.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
285
The slide uses a Q&A transcript format to detail a specific medical case study involving drug safety concerns.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
286
The slide highlights a potential safety concern and a perceived lack of transparency or concern from the manufacturer's sales representative.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
289
The slide uses a Wikipedia table to explain DEA drug schedules to frame the competitive landscape.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
290
The slide uses direct quotes from KOLs and specialists to undermine a specific company value proposition.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
292
The slide uses direct quotes to expose a contradiction between the company's marketing (non-controlled status) and the actual physician experience (high administrative burden).Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
293
The slide uses highlighted text to emphasize key negative sentiments from expert interviews.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
295
The slide uses a screenshot of the Wakix website to highlight the specific claim being challenged.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
296
The slide uses screenshots of two different websites to demonstrate consistent messaging across patient and HCP channels.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
298
The slide uses a 'fraud-exposure' approach by highlighting circular citations and methodological weaknesses in the foundational research.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
299
The slide uses scientific data to challenge the validity of the drug's efficacy claims by highlighting the high dosage required in animal models.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
302
The slide uses box-whisker plots to demonstrate a lack of correlation between histamine/metabolite levels and various sleep disorder etiologies.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
309
The slide uses a combination of summary points and direct excerpts from a pharmacology consultant's review to build a case of scientific negligence or misrepresentation.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
310
The slide uses a specific scientific paper (Lin et al., 2007) to argue that the drug's mechanism is scientifically implausible based on the provided data.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
312
The slide uses a combination of summary text, a screenshot of the original study abstract, and a pull-quote from an expert review to discredit the study's findings.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
313
Includes a quote from a pharmacology consultant comparing pitolisant to antihistamines.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
316
The slide uses a 'villain' narrative by comparing Harmony's practices to the Insys case and official government fraud alerts.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit